Mark Schallenberger
Chief Operating Officer at XTANT MEDICAL HOLDINGS, INC.
Net worth: 447 753 $ as of 2024-03-30
Profile
Mark A.
Schallenberger is currently the Chief Operating Officer at Xtant Medical Holdings, Inc. He previously worked as the Senior Director-Marketing & Product Development at DCI Donor Services Tissue Bank from 2017 to 2019, and as the Chief Operations Officer at Surgenex LLC from 2019 to 2023.
Mr. Schallenberger has a graduate degree from The Scripps Research Institute and an undergraduate degree from The University of Montana.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-02 | 382,695 ( 0.29% ) | 447 753 $ | 2024-03-30 |
Mark Schallenberger active positions
| Companies | Position | Start |
|---|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Chief Operating Officer | 2023-01-15 |
Former positions of Mark Schallenberger
| Companies | Position | End |
|---|---|---|
| Surgenex LLC | Chief Operating Officer | 2022-12-31 |
| DCI Donor Services Tissue Bank | Corporate Officer/Principal | 2019-05-31 |
Training of Mark Schallenberger
| The Scripps Research Institute | Graduate Degree |
| The University of Montana | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Surgenex LLC | |
| DCI Donor Services Tissue Bank |
- Stock Market
- Insiders
- Mark Schallenberger
